Los Angeles Capital Management
BIOA

Los Angeles Capital Management’s BioAge Labs BIOA Stock Holding History

Los Angeles Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,899
Closed -$593K – 2529
2026
Q1 		$593K Sell
33,899
-6,489
-16% -$125K ﹤0.01% 816
2025
Q4 		$312K Sell
40,388
-80,541
-67% -$714K ﹤0.01% 1079
2025
Q3 		$711K Buy
+120,929
New +$566K ﹤0.01% 809

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Los Angeles Capital Management's BIOA Position: Q2 2026 in Review

Los Angeles Capital Management sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 33,899 shares — an estimated $593K sold.

Los Angeles Capital Management first reported a position in BIOA in Q3 2025 and held it in 3 quarters. The position peaked at $711K in Q3 2025. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Los Angeles Capital Management reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 33,899 BioAge Labs shares in Q2 2026, an estimated $593K.
  • Los Angeles Capital Management first reported a position in BioAge Labs in Q3 2025 and held it in 3 quarters.
  • Los Angeles Capital Management's BioAge Labs position peaked at $711K in Q3 2025.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.